Jenkins David K, Swanson Gregory P, Jhavar Sameer G, Wagner Kristofer R, Ha Chul S, Chen Wencong
Baylor Scott & White Medical Center - Temple, 2401 S 31stSt, Temple, TX 76508, US.
University of Texas Health Science Center San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229, US.
Rep Pract Oncol Radiother. 2020 May-Jun;25(3):442-446. doi: 10.1016/j.rpor.2020.03.019. Epub 2020 Apr 16.
We sought to evaluate the effect of radiation therapy on post-prostatectomy urinary quality of life in prostate cancer patients.
In some men with non-metastatic prostate cancer, radiation therapy is indicated following prostatectomy. The radiation toxicity and quality of life considerations are unique in the post-prostatectomy setting.
A total of 106 patients receiving post-prostatectomy radiation therapy completed the Expanded Prostate Cancer Index Composite questionnaire before radiation and at 2-year follow-up. The primary outcomes of this study were the urinary domain summary score and subscale scores. Planned analysis was performed based on time interval from prostatectomy to radiation therapy.
Among the 106 patients analyzed, the mean urinary domain summary score worsened at 2-year follow-up after radiation therapy, lowering from 77.23-72.51 (p = 0.0085). Similar worsening was observed in the subscales of function (p = 0.003), bother (p = 0.0397), and incontinence (p = 0.0003). Urinary incontinence showed the greatest observable change among subscales. While the summary score worsened (p = 0.0031) among patients receiving radiation therapy more than 1 year after prostatectomy, it did not show statistically significant change in those treated 1 year or less after prostatectomy.
Our results demonstrate that post-prostatectomy radiation therapy is associated with modest declines in reportable urinary quality of life. Patients receiving radiation therapy more than 1 year after prostatectomy showed greater worsening of urinary quality of life, which indicates that there may be no functional advantage to delaying radiation therapy beyond the initial postoperative period.
我们试图评估放射治疗对前列腺癌患者前列腺切除术后尿生活质量的影响。
在一些非转移性前列腺癌男性患者中,前列腺切除术后需要进行放射治疗。放射毒性和生活质量考量在前列腺切除术后的情况下具有独特性。
共有106例接受前列腺切除术后放射治疗的患者在放疗前及2年随访时完成了扩展前列腺癌指数综合问卷。本研究的主要结局是尿领域总结评分和子量表评分。根据从前列腺切除术到放射治疗的时间间隔进行计划分析。
在分析的106例患者中,放疗后2年随访时尿领域平均总结评分恶化,从77.23降至72.51(p = 0.0085)。在功能(p = 0.003)、困扰(p = 0.0397)和尿失禁(p = 0.0003)子量表中也观察到类似的恶化。尿失禁在各子量表中变化最为明显。前列腺切除术后1年以上接受放疗的患者总结评分恶化(p = 0.0031),而前列腺切除术后1年或更短时间接受治疗的患者总结评分无统计学显著变化。
我们的结果表明,前列腺切除术后放射治疗与可报告的尿生活质量适度下降有关。前列腺切除术后1年以上接受放疗的患者尿生活质量恶化更明显,这表明在术后初期之后延迟放疗可能没有功能上的优势。